2010 ◽
Vol 13
(7)
◽
pp. A438
2010 ◽
Vol 13
(7)
◽
pp. A549
2011 ◽
Vol 14
(7)
◽
pp. A275
M. Jakubczyk
◽
J. Pawęska
◽
M. Niewada
◽
H. Berak
◽
M. Szkultecka-Dębek
◽
...
2012 ◽
Vol 15
(6)
◽
pp. 894-906
◽
Jing He
◽
James M. Bowen
◽
Feng Xie
◽
Ron Goeree
2015 ◽
Vol 35
(3)
◽
pp. 197-209
◽
Chi Zhang
◽
Weixia Ke
◽
Yanhui Gao
◽
Shudong Zhou
◽
Li Liu
◽
...
2011 ◽
Vol 14
(7)
◽
pp. A277
M. Jakubczyk
◽
J. Pawèska
◽
M. Niewada
◽
H. Berak
◽
M. Szkultecka-dèbek
◽
...
2012 ◽
Vol 15
(7)
◽
pp. A330
W. Zhang
◽
H. Zhuang
◽
H. Ren
◽
X. Dou
◽
W. Chen
2008 ◽
Vol 26
(11)
◽
pp. 937-949
◽
D Eldon Spackman
◽
David L Veenstra
2006 ◽
Vol 9
(6)
◽
pp. A300
E Kowalik
◽
M Niewada
◽
M Jakubczyk
◽
A Horban
◽
H Berak
◽
...
2007 ◽
Vol 22
(9)
◽
pp. 1357-1359
◽
Yock Young Dan
◽
Seng Gee Lim
Close
Export Citation Format
Close
Share Document
Close
PIN44 COST-EFFECTIVENESS ANALYSIS OF 1 YEAR PEGINTERFERON ALFA-2A VERSUS 4 YEARS ENTECAVIR FOR THE TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B IN CHINA
